Aperam is trading at €43.44, down -4.40%, likely reflecting continued selling and profit-taking after its recent rally.
- Aperam extended its decline from €45.56 on August 18, 2026; no fresh company announcement, earnings surprise, or broker action was identified for August 20–21.
- European equities also closed lower amid geopolitical tensions and higher oil prices, but the modest regional move does not clearly explain Aperam’s larger decline.
- No definitive catalyst was found.